Upward Trajectory: Resmed Inc. (RMD) Posts a Slidee, Closing at 212.88

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

The closing price of Resmed Inc. (NYSE: RMD) was $212.88 for the day, down -1.52% from the previous closing price of $216.16. In other words, the price has decreased by -$1.52 from its previous closing price. On the day, 0.98 million shares were traded. RMD stock price reached its highest trading level at $212.92 during the session, while it also had its lowest trading level at $210.39.


Our analysis of RMD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 131.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.70. For the most recent quarter (mrq), Quick Ratio is recorded 1.97 and its Current Ratio is at 3.04. In the meantime, Its Debt-to-Equity ratio is 0.25 whereas as Long-Term Debt/Eq ratio is at 0.24.

On October 27, 2023, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight and also lowered its target price recommendation from $180 to $169.

RBC Capital Mkts Downgraded its Outperform to Sector Perform on October 12, 2023, whereas the target price for the stock was revised from $273 to $202.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 29 ’24 when Drexler Karen sold 425 shares for $214.92 per share. The transaction valued at 91,341 led to the insider holds 8,446 shares of the business.

Rider Michael J sold 81 shares of RMD for $14,580 on Mar 04 ’24. The Global General Counsel now owns 6,607 shares after completing the transaction at $180.00 per share. On Mar 01 ’24, another insider, Rider Michael J, who serves as the Global General Counsel of the company, sold 200 shares for $173.25 each. As a result, the insider received 34,650 and left with 6,688 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMD now has a Market Capitalization of 31273564160 and an Enterprise Value of 32663459840. As of this moment, Resmed’s Price-to-Earnings (P/E) ratio for their current fiscal year is 32.76, and their Forward P/E ratio for the next fiscal year is 24.30. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.82 while its Price-to-Book (P/B) ratio in mrq is 6.75. Its current Enterprise Value per Revenue stands at 7.125 whereas that against EBITDA is 22.661.

Stock Price History:

Over the past 52 weeks, RMD has reached a high of $237.26, while it has fallen to a 52-week low of $132.24. The 50-Day Moving Average of the stock is 11.13%, while the 200-Day Moving Average is calculated to be 23.61%.

Shares Statistics:

RMD traded an average of 1.10M shares per day over the past three months and 1499010 shares per day over the past ten days. A total of 147.06M shares are outstanding, with a floating share count of 145.74M. Insiders hold about 0.80% of the company’s shares, while institutions hold 59.27% stake in the company. Shares short for RMD as of 1713139200 were 7945276 with a Short Ratio of 7.20, compared to 1710460800 on 7660964. Therefore, it implies a Short% of Shares Outstanding of 7945276 and a Short% of Float of 6.17.

Dividends & Splits

With its trailing 12-month dividend rate of 1.88, RMD has a forward annual dividend rate of 2.36. Against a Trailing Annual Dividend Yield of 0.008716618The stock’s 5-year Average Dividend Yield is 0.87.

Most Popular

[the_ad id="945"]